“…Given the rather cost-effective and safe outcomes from recent observational experiences with HCQ, 8 , 9 , 11 , 14 , 16 , 31 pending the outcomes of the ongoing clinical trials, we would propose, prepare now and implement promptly the following outline protocol for this and possibly subsequent outbreaks of COVID-19 ( Figure 1 ). - By way of preparation, ensure the availability of sufficient quantities of the (easily prepared, small molecule) drug in oral doses, together with guidelines for prescription and use consistent with the regime outlined in this protocol.
…”